[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] LUINI A,GATTI G,BALLARDINI B,et al.Development of axillary surgery in breast cancer[J].Ann Oncol,2005,16(2):259-262.
[3] NAOUM GE,ROBERTS S,BRUNELLE CL,et al.Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control:Long-term results from a prospective screening trial[J].J Clin Oncol,2020,38(29):3430-3438.
[4] 中国抗癌协会乳腺癌专业委员会,中华医学会肿瘤学分会乳腺肿瘤学组.中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J].中国癌症杂志,2023,33(12):1092-1187.
The Society of Breast Cancer China Anti-Cancer Association,Breast Oncology Group of the Oncology Branch of the Chinese Medical Association.Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association(2024 edition)[J].China Oncology,2023,33(12):1092-1187.
[5] MARINO MA,AVENDANO D,ZAPATA P,et al.Lymph node imaging in patients with primary breast cancer:Concurrent diagnostic tools[J].Oncologist,2020,25(2):e231-e242.
[6] BANSAL GJ,JAIPAL A,WU GKC,et al.Diagnostic accuracy of magnetic resonance imaging to evaluate axillary lymph node status in breast cancer patients receiving neoadjuvant chemotherapy[J].Br J Radiol,2023,96(1143):20220904.
[7] JI S,YANG D,LEE J,et al.Synthetic MRI:technologies and applications in neuroradiology[J].J Magn Reson Imaging,2022,55(4):1013-1025.
[8] MENG T,HE N,HE H,et al.The diagnostic performance of quantitative mapping in breast cancer patients:a preliminary study using synthetic MRI[J].Cancer Imaging,2020,20:88.
[9] DU S,GAO S,ZHANG L,et al.Improved discrimination of molecular subtypes in invasive breast cancer:comparison of multiple quantitative parameters from breast MRI[J].Magn Reson Imaging,2021,77:148-158.
[10] TSUKADA H,TSUKADA J,SCHRADING S,et al.Accuracy of multi-parametric breast MR imaging for predicting pathological complete response of operable breast cancer prior to neoadjuvant systemic therapy[J].Magn Reson Imaging,2019,62:242-248.
[11] SCARANELO AM,EIADA R,JACKS LM,et al.Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis:study of reproducibility and reliability[J].Radiology,2012,262(2):425-434.
[12] SCHIPPER RJ,PAIMAN ML,BEETS-TAN RG,et al.Diagnostic performance of dedicated axillary T2-and diffusion-weighted MR imaging for nodal staging in breast cancer[J].Radiology,2015,275(2):345-355.
[13] ZHAO L,LIANG M,XIE L,et al.Prediction of pathological prognostic factors of rectal cancer by relaxation maps from synthetic magnetic resonance imaging[J].Eur J Radiol,2021,138:109658.
[14] SPIEKER M,KATSIANOS E,GASTL M,et al.T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy[J].Eur Heart J Cardiovasc Imaging,2018,19(5):574-582.
[15] WANG P,HU S,WANG X,et al.Synthetic MRI in differentiating benign from metastatic retropharyngeal lymphnode:combination with diffusion-weighted imaging[J].Eur Radiol,2023,33(1):152-161.
[16] GE YX,HU SD,WANG Z,et al.Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes inrectal cancer[J].Eur Radiol,2021,31(5):3347-3354.
[17] MOHARAMZAD Y,DAVARPANAH AH,YAGHOBI JOYBARI A,et al.Diagnostic performance of apparent diffusion coefficient(ADC) for differentiating endometrial carcinoma from benign lesions:a systematic review and meta-analysis[J].Abdom Radiol(NY),2021,46(3):1115-1128.
[18] TSVETKOVA S,DOYKOVA K,VASILSKA A,et al.Differentiation of benign and malignant breast lesions using ADC values and ADC ratio in breast MRI[J].Diagnostics(Basel),2022,12(2):332.
[19] GAO W,ZHANG S,GUO J,et al.Investigation of synthetic relaxometry and diffusion measures in the differentiation of benign and malignant breast lesions as compared to BI-RADS[J].J Magn Reson Imaging,2021,53(4):1118-1127.